v3.22.2.2
GRANT COLLABORATON AGREEMENT (Details Narrative) - Cystic Fibrosis Foundation [Member] - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Feb. 10, 2021
Sep. 30, 2022
Sep. 30, 2022
Product Information [Line Items]      
Grants Receivable $ 2,170    
Reduction of research and development expense     $ 1,510
Other Expenses   $ 181 $ 338
Revenue Benchmark [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration Risk, Percentage 10.00%